BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Interaction of Resveratrol and Genistein with Nucleic Acids

  • Usha, Subbiah (Department of Genetics, Dr. ALM Post Graduate Institute of Basic Medical Science, University of Madras) ;
  • Johnson, Irudayam Maria (Department of Genetics, Dr. ALM Post Graduate Institute of Basic Medical Science, University of Madras) ;
  • Malathi, Raghunathan (Department of Genetics, Dr. ALM Post Graduate Institute of Basic Medical Science, University of Madras)
  • Published : 2005.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Resveratrol (RES) and genistein (GEN) are the dietary natural products known to possess chemopreventive property and also the ability to repair DNA damage induced by mutagens/carcinogens. It is believed that the therapeutic activity of these compounds could be primarily due to their interaction with nucleic acids but detailed reports are not available. We here explore the interaction of these drugs with nucleic acids considering DNA and RNA as a potential therapeutic target. The interaction of RES and GEN has been analysed in buffered solution with DNA [saline sodium citrate (SSC)] and RNA [tris ethylene diammine tetra acetic acid (TE)] using UV-absorption and Fourier transform infrared (FTIR) spectroscopy. The UV analysis revealed lesser binding affinity with nucleic acids at lower concentration of RES (P/D = 5.00 and 10.00), while at higher drug concentration (P/D = 0.75, 1.00 and 2.50) hyperchromic effect with shift in the ${\lambda}_{max}$ is noted for DNA and RNA. A major RES-nucleic acids complexes was observed through base pairs and phosphate backbone groups with K = $35.782\;M^{-1}$ and K = $34.25\;M^{-1}$ for DNA-RES and RNA-RES complexes respectively. At various concentrations of GEN (P/D = 0.25, 0.50, 0.75, 1.00 and 2.50) hyperchromicity with shift in the ${\lambda}_{max}$ from 260 $\rightarrow$ 263 om and 260 $\rightarrow$ 270 nm is observed for DNA-GEN and RNA-GEN complexes respectively. The binding constant (from UV analysis) for GEN-nucleic acids complexes could not be obtained due to GEN absorbance overlap with that of nucleic acids at 260 nm. Nevertheless a detailed analysis with regard to the interaction of these drugs (RES/GEN) with DNA and RNA could feasibly be understood by FTIR spectroscopy. The NH band of free DNA and RNA which appeared at $3550-3100\;cm^{-1}$ and $3650-2700\;cm^{-1}$ shifted to $3450-2950\;cm^{-1}$ and $3550-3000\;cm^{-1}$ in DNA-RES and RNA-RES complexes respectively. Similarly shifts corresponding to $3650-3100\;cm^{-1}$ and $3420-3000\;cm^{-1}$ have been observed in DNA-GEN and RNA-GEN complexes respectively. The observed reduction in NH band of free nucleic acids upon complexation of these drugs is an indication of the involvement of the hydroxyl (OH) and imino (NH) group during the interaction of the drugs and nucleic acids (DNA/RNA) through H-bonded formation. The interaction of RES and GEN with bases appears in the order of G $\geq$ T > C > A and A > C $\geq$ T > G. Further interaction of these natural compounds with DNA and RNA is also supported by changes in the vibrational frequency (shift/intensity) in symmetrical and asymmetrical stretching of aromatic rings of drugs in the complex spectra. No appreciable shift is observed in the DNA and RNA marker bands, indicating that the B-DNA form and A-family conformation of RNA are not altered during their interaction with RES and GEN.

Keywords

References

  1. Ahmad, R., Arakawa, H. and Tajmir-Riahi, H. A. (2003) A comparative study of DNA complexation with Mg(ll) and Ca(ll) in aqueous solution: Major and minor groove bindings. Biophys. J. 84, 2460-2466 https://doi.org/10.1016/S0006-3495(03)75050-4
  2. Ahmed, O. A., Nafisi, S., Mohajerani, N. and Tajmir-Riahi, H. A. (2003) Thallium-DNA complexes in aqueous solution. Major or minor groove binding. J. Biomol. Struct. Dyn. 20, 561-565 https://doi.org/10.1080/07391102.2003.10506872
  3. Ahmad, A., Asad, S. F., Singh, S. and Hadi, S. M. (2000) DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation. Cancer Lett. 154, 29-37 https://doi.org/10.1016/S0304-3835(00)00351-7
  4. Adlercreutz, H. and Mazur, W. (1997) Phyto-estrogens and western diseases. Ann. Med. 29, 95-120 https://doi.org/10.3109/07853899709113696
  5. Alex, S. and Dupuis, P. (1989) FTIR and Raman investigation of cadmium binding by DNA. Inorg. Chim. Acta. 157, 271-281 https://doi.org/10.1016/S0020-1693(00)80552-6
  6. Brahms, S., Brahms, J. and Pilet, J. (1974) Infrared studies on the backbone conformation of nucleic acids. Isr. J. Chem. 12, 153- 163 https://doi.org/10.1002/ijch.197400015
  7. Chandrasekar, K., Shyla, J. H. and Malathi, R. (2000) Can antitumor platinum compounds be effective against Candida albicans? - a screening assay using disk diffusion method. J. Clin Microbiol. 38, 3905
  8. Delmas, D., Passilly-Degrace, P., Jannin, B., Malki, M. C. and Latruffe, N. (2002) Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Inter. J. Mol. Med. 10, 193-199
  9. Djoman, M. C., Neault, J. F., Hashemi-Fesharaky, S. and Tajmir- Riahi, H. A. (1998) RNA Ascorbate interaction. J. Biomol. Str. Dyn. 15, 1115-1119 https://doi.org/10.1080/07391102.1998.10509005
  10. Fontecave, M., Leoivre, M., Elleingand, E., Gerez, C. and Guittet, O. (1998) Resveratrol a remarkable inhibitor of ribonucleotide reductase, Resveratrol a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421, 277-279 https://doi.org/10.1016/S0014-5793(97)01572-X
  11. Fukuhara, K. and Miyata, N. (1998) Resveratrol as a new type of DNA-cleaving agent. Bioorg Med Chem Lett. 8, 87-92 https://doi.org/10.1016/S0960-894X(97)10196-2
  12. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Has, T., Mon-tesano, R. and Schweigerer, L. (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA 90, 2690-2694 https://doi.org/10.1073/pnas.90.7.2690
  13. Johnson, I. M., Bhuvan Kumar, S. G. and Malathi, R. (2003) RNA binding efficacy of theophylline, theobromine and caffeine. J. Biomol. Str. Dyn. 20, 687-692 https://doi.org/10.1080/07391102.2003.10506885
  14. Johnson, I. M. and Malathi, R. (2005). Methylxanthines binding with yeast total RNA in the presence of $Mg^{2+}$: A speed vac centrifugation facilitated solid-state FTIR analysis. Anal. Biochem. (In press) https://doi.org/10.1016/j.ab.2004.09.032
  15. Jang, M. and Pezzuto, J. M. (1999) Cancer chemopreventive activity of resveratrol. Drug Exp. Clin. Res. 25, 65-77
  16. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Fransworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C. and Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220. https://doi.org/10.1126/science.275.5297.218
  17. Helen, A. J. and Gibson, I. (1998) The therapeutic potential of ribozymes. Blood 91, 371-382
  18. Leclerq, G. and Heuson, J. C. (1979) Physiological and pharmacological effects of estrogens in breast cancer. Biochim. Biophys. Acta 560, 427-455
  19. Nishino, H. and Aoike, A. (1993) Genistein arrests cell cycle progression at G2-M. Cancer Res. 53, 1328-1331
  20. Natarajan, G., Malathi, R. and Holler, E. (1998) Helix-coil transitions in DNA modified by novel Pt (II) complexes: A pH melting study. J. Biomol. Str. Dyn. 15, 1173-1180 https://doi.org/10.1080/07391102.1998.10509011
  21. Natarajan, G., Malathi, R. and Holler, E. (1999) Increased DNAbinding activity of carboplatin in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited. Biochem. Pharmacol. 58, 1625- 1629 https://doi.org/10.1016/S0006-2952(99)00250-6
  22. Silverstein, R. M. and Webster, F. X. (1997) Characteristic group frequencies of organic molecules; in Spectrometric Identification of Organic Compounds, pp. 95-180, John Wiley and Sons, New York, USA
  23. Stephanos, J. J. (1996) Drug-protein interactions: two-site binding of heterocyclic ligands to monomeric hemoglobin. J. Inorg. Biochem. 62, 155-169 https://doi.org/10.1016/0162-0134(95)00144-1
  24. Sun, N. J., Woo, S. H., Cassady, I. M. and Snapka, R. M. (1998) DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Nat. Prod. 61, 362-366 https://doi.org/10.1021/np970488q
  25. Soni, P. L. and Chawla, H. M. (1994) Spectroscopy; in Text Book of Organic Chemistry, 26th ed. pp. 1257-1279, Sultan Chand and Sons, New Delhi, India
  26. Tor, Y. (1999) RNA and the small molecule world, Angew. Chem. Int. Ed. 38, 1579-1581 https://doi.org/10.1002/(SICI)1521-3773(19990601)38:11<1579::AID-ANIE1579>3.0.CO;2-H
  27. Win, W., Cao, Z., Peng, X., Trush, M. A. and Li, Y. (2002) Different effect of genistein and resveratrol on oxidative DNA damage in vitro. Mutat. Res. 513, 113-120 https://doi.org/10.1016/S1383-5718(01)00303-5

Cited by

  1. Resveratrol: Its Biologic Targets and Functional Activity vol.11, pp.11, 2009, https://doi.org/10.1089/ars.2008.2412
  2. Novel isoxazole polycyclic aromatic hydrocarbons as DNA-intercalating agents vol.51, 2012, https://doi.org/10.1016/j.ejmech.2012.02.038
  3. Determination of DNA Hypermethylation Using Anti-cancer Drug-Temozolomide vol.28, pp.5, 2016, https://doi.org/10.1002/elan.201501027
  4. Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms vol.1348, pp.1, 2015, https://doi.org/10.1111/nyas.12796
  5. Structural modeling for DNA binding to antioxidants resveratrol, genistein and curcumin vol.151, 2015, https://doi.org/10.1016/j.jphotobiol.2015.07.007
  6. Functional Characterization of a Flavonoid Glycosyltransferase Gene from Withania somnifera (Ashwagandha) vol.170, pp.3, 2013, https://doi.org/10.1007/s12010-013-0230-2
  7. Possible Inhibition of Group I Intron RNA by Resveratrol and Genistein vol.24, pp.1, 2006, https://doi.org/10.1080/07391102.2006.10507095
  8. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway vol.275, pp.3, 2014, https://doi.org/10.1016/j.taap.2014.01.011
  9. Take a break--resveratrol in action on DNA vol.29, pp.2, 2008, https://doi.org/10.1093/carcin/bgm276
  10. DNA interaction with flavone and hydroxyflavones vol.975, pp.1-3, 2010, https://doi.org/10.1016/j.molstruc.2010.04.039
  11. Study of DNA–emodin interaction by FTIR and UV–vis spectroscopy vol.111, 2012, https://doi.org/10.1016/j.jphotobiol.2012.03.012
  12. Isoxazolidinyl polycyclic aromatic hydrocarbons as DNA-intercalating antitumor agents vol.46, pp.1, 2011, https://doi.org/10.1016/j.ejmech.2010.10.023
  13. Grandivittin as a natural minor groove binder extracted from Ferulago macrocarpa to ct-DNA, experimental and in silico analysis vol.258, 2016, https://doi.org/10.1016/j.cbi.2016.08.020
  14. Astragalin from Cassia alata Induces DNA Adducts in Vitro and Repairable DNA Damage in the Yeast Saccharomyces cerevisiae vol.13, pp.12, 2012, https://doi.org/10.3390/ijms13032846
  15. Modulation of DNA intercalation by resveratrol and genistein vol.284, pp.1-2, 2006, https://doi.org/10.1007/s11010-005-9013-6
  16. Electrochemical and spectroscopic characterization of the interaction between DNA and Cu(II)–naringin complex vol.45, pp.5, 2007, https://doi.org/10.1016/j.jpba.2007.08.007
  17. Study of interaction between tiagabine HCl and 2-HPβCD: investigation of inclusion process vol.68, pp.1-2, 2010, https://doi.org/10.1007/s10847-009-9732-5
  18. Synthesis and biological activity of novel bifunctional isoxazolidinyl polycyclic aromatic hydrocarbons vol.20, pp.16, 2012, https://doi.org/10.1016/j.bmc.2012.06.035
  19. Recent advances in small organic molecules as DNA intercalating agents: Synthesis, activity, and modeling vol.74, 2014, https://doi.org/10.1016/j.ejmech.2013.11.029
  20. Physico-chemical characterization of an amphiphilic cyclodextrin/genistein complex vol.51, pp.5, 2010, https://doi.org/10.1016/j.jpba.2009.11.025
  21. UV–vis and FTIR–ATR spectroscopic techniques to study the inclusion complexes of genistein with β-cyclodextrins vol.44, pp.1, 2007, https://doi.org/10.1016/j.jpba.2007.01.054
  22. Study of curcumin and genistein interactions with human serum albumin vol.49, pp.2, 2009, https://doi.org/10.1016/j.jpba.2008.11.035